Status:

COMPLETED

PCa Patients Managed With ADT to Examine the Effect of Nutritional Guidance and Aerobic/Resistance Fitness Training

Lead Sponsor:

CMX Research

Collaborating Sponsors:

Sanofi

Conditions:

Cancer of the Prostate

Eligibility:

MALE

18+ years

Brief Summary

The purpose of this observational study is to examine the level of activity in the prostate cancer population treated with Androgen Deprivation Therapy (ADT).

Detailed Description

The aim of the current observational study will be to examine the level of activity in the prostate cancer population treated with ADT therapy; specifically, the impact of physical activity levels alo...

Eligibility Criteria

Inclusion

  • Male patient aged ≥ 18 years old
  • Able to read and sign an approved Informed Consent Form (ICF)
  • Diagnosed with locally advanced or metastatic prostate cancer
  • Patient is treatment naive for ADT or has started ADT (3 or 4 month depot injection) AND has not received more than 1 treatment of 3 or 4 month ADT OR Patient is on intermittent therapy with an ADT agent and will be restarting ADT (3 or 4 month depot injection)
  • ECOG (Eastern Cooperative Oncology Group) score of ≤ 2
  • Willingness to track weekly physical activities with or without participating in a home based exercise program during the course of this study. The physical activities will be tracked with a weekly activity log or a NIKE+ Fuelband

Exclusion

  • Currently participating in a clinical study or observational study
  • Has a survival expectancy of \< 2 years
  • Has any other condition that, in the opinion of the treating physician, may affect the patient's health or outcome of the trial

Key Trial Info

Start Date :

November 1 2013

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

July 1 2020

Estimated Enrollment :

271 Patients enrolled

Trial Details

Trial ID

NCT04057859

Start Date

November 1 2013

End Date

July 1 2020

Last Update

January 24 2022

Active Locations (23)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 6 (23 locations)

1

Southern Interior Medical Research Inc.

Kelowna, British Columbia, Canada, V1W 4V5

2

Silverado Research Inc.

Victoria, British Columbia, Canada, V8T 2C1

3

Barrie Urology Group

Barrie, Ontario, Canada, L4M 7G1

4

Euroscope Inc.

Barrie, Ontario, Canada, L4M 7G1